Tenderwize
Zurück zur Suche

Supply of human plasma-derived medicines

Fédération des Hôpitaux Luxembourgeois (FHL)·Bertrange, Luxembourg·Expired · Jun 16, 2026·Neg W Call·Supplies·Framework
Structured notice only
Original notice title

Centrale d'achat FHL: fourniture de médicaments dérivés du plasma humain.

50/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkExpired
Why this score?

Opportunity

50 / 100

Complexity

55 / 100

Risk factors

Estimated value, lot 2 title, and award/selection criteria are not provided in the notice, increasing uncertainty.

Tenders must be in French or German; non-fluent bidders may face challenges or translation costs.

No procurement documents available

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 2 lots
  • Supply of human plasma-derived medicinal products (albumins and immunoglobulins) for intravenous administration.
  • Framework agreement with four hospitals: Centre Hospitalier Émile Mayrisch (CHEM), Centre Hospitalier de Luxembourg (CHL), Centre Hospitalier du Nord (CHdN), and Hôpitaux Robert Schuman (HRS).
Show full summary

This tender by the Fédération des Hôpitaux Luxembourgeois (FHL) concerns a framework agreement for the supply of plasma-derived medicinal products (albumins and immunoglobulins) to four Luxembourg hospitals. The contract is for 4 years, with two lots: Lot 1 (Albumines) and Lot 2 (likely immunoglobulins, though title missing in structured data). The procedure is a negotiated procedure with call for competition. No estimated value is provided. Submission is electronic via the e-procurement platform, with deadlines 2026-06-16 11:00 (local time). Languages: French and German. The notice is a correction (update-add) to a previous notice (319661-2026).

Risks

Estimated value, lot 2 title, and award/selection criteria are not provided in the notice, increasing uncertainty.

Tenders must be in French or German; non-fluent bidders may face challenges or translation costs.

No procurement documents available

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Supplies must meet specifications for human plasma-derived medicinal products.
  • Framework agreement duration of 4 years.

Administrative

  • Electronic submission mandatory via PMP platform.

Requirements may be incomplete.

Buyer

Name

Fédération des Hôpitaux Luxembourgeois (FHL)

Location

Bertrange, LUX

Identifier

LU23830047

Lots (2)

LOT-0001

Albumines

Supply of albumins in injectable forms: 12.5g/250ml 5%, 25g/500ml 5%, and 20g/100ml 20%. Framework agreement for 4 years. Submission via PMP platform (URL provided).

SuppliesFrameworkElectronic submission

Location

Luxembourg

Category

Plasma extracts

Deadline

Expired Jun 16, 2026

LOT-0002

LOT-0002

Second lot for plasma-derived medicinal products (likely immunoglobulins based on tender description). Framework agreement for 4 years. Submission via PMP platform. No title or detailed description provided in structured data.

SuppliesFrameworkElectronic submission

Location

Luxembourg

Category

Plasma extracts

Deadline

Expired Jun 16, 2026

Procurement Details

Publication date
25 May 2026
Notice type
Contract notice — standard
Languages
French, German

Reference metadata

Notice subtype
16
Notice version
1
Legal basis
32014L0024

Reference IDs

Tender ID
356193-2026
Source notice ID
5f9ec54e-bec0-4b6a-869b-95861852b213

Documents (1)

Similar tenders